大博医疗：10月28日召开董事会会议

Group 1 - The core point of the article is that Dabo Medical (SZ 002901) held its 20th meeting of the third board of directors on October 28, 2025, to review proposals related to the revision and establishment of certain governance systems [1] - For the first half of 2025, Dabo Medical's revenue composition is entirely from the medical device manufacturing industry, accounting for 100.0% [1] - As of the time of reporting, Dabo Medical has a market capitalization of 23.1 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation into a "slow bull" new pattern [1]